Now live: Pro — the full 13F research suite for serious investorsSee pricing →
← Tracker

Institutional

Memorial Sloan Kettering Cancer Center

CIK 0001566787
$24.6M
Reported AUM
3
Positions
Q3 2023
Period
2023-11-14
Filed

Editorial summary

Summary for Memorial Sloan Kettering Cancer Center · Q3 2023 is not yet generated. It will appear here after the next nightly run.

Portfolio · Q3 2023

GDX$19.9MORIC$3.6MY-MABSMC

Top holdings

#StockIssuerPriceDay %1Y Gr.5Y Gr.Value% of bookΔ shares (QoQ)Status
1GDXVANECK ETF TRUST$75.943.23%45.00%148.23%$19.9M80.92%HELD
2ORICORIC PHARMACEUTICALS INC$11.340.49%11.46%-48.94%$3.6M14.84%HELD
3YMABUSDY-MABS THERAPEUTICS INC$1.0M4.24%HELD

Source: SEC EDGAR · accession 0000921895-23-002627. 13F discloses long positions only — shorts, foreign equities, and options are excluded.